CLINICAL_TRIALS
trial_result
· 2025-12-10
Clinical Trial Update: STA363 in the Treatment of Lumbar Disc Herniation [Phase 1]
Summary
A Phase 1 trial evaluating STA363 for lumbar disc herniation has completed, according to Stayble Therapeutics.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Stayble Therapeutics | Conditions: Lumbar Disc Herniation | Phase 1 | Status: COMPLETED